SMTL ID : 2pzy.5 (4 other biounits)

Structure of MK2 Complexed with Compound 76

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

homo-12-mer

Ligands

6 x B18: (4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE(Non-covalent)

B18.1: 15 residues within 4Å: Chain A: V.29, L.30, L.32, G.33, V.38, A.51, K.53, M.98, E.99, C.100, L.101, D.102, L.153, T.166, D.167 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.38, A:A.51, A:L.153 Hydrogen bonds: A:L.30, A:L.101, A:T.166, A:D.167 B18.2: 15 residues within 4Å: Chain B: L.30, L.32, V.38, A.51, K.53, V.78, M.98, E.99, C.100, L.101, D.102, N.151, L.153, T.166, D.167 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:V.38, B:A.51, B:V.78, B:L.101 Hydrogen bonds: B:L.30, B:L.30, B:L.101, B:D.167, B:D.167 B18.4: 15 residues within 4Å: Chain E: V.29, L.30, L.32, G.33, V.38, A.51, K.53, M.98, E.99, C.100, L.101, D.102, L.153, T.166, D.167 7 PLIP interactions: 7 interactions with chain E Hydrophobic interactions: E:V.38, E:A.51, E:L.153 Hydrogen bonds: E:L.30, E:L.101, E:T.166, E:D.167 B18.5: 15 residues within 4Å: Chain F: L.30, L.32, V.38, A.51, K.53, V.78, M.98, E.99, C.100, L.101, D.102, N.151, L.153, T.166, D.167 9 PLIP interactions: 9 interactions with chain F Hydrophobic interactions: F:V.38, F:A.51, F:V.78, F:L.101 Hydrogen bonds: F:L.30, F:L.30, F:L.101, F:D.167, F:D.167 B18.7: 15 residues within 4Å: Chain I: V.29, L.30, L.32, G.33, V.38, A.51, K.53, M.98, E.99, C.100, L.101, D.102, L.153, T.166, D.167 7 PLIP interactions: 7 interactions with chain I Hydrophobic interactions: I:V.38, I:A.51, I:L.153 Hydrogen bonds: I:L.30, I:L.101, I:T.166, I:D.167 B18.8: 15 residues within 4Å: Chain J: L.30, L.32, V.38, A.51, K.53, V.78, M.98, E.99, C.100, L.101, D.102, N.151, L.153, T.166, D.167 9 PLIP interactions: 9 interactions with chain J Hydrophobic interactions: J:V.38, J:A.51, J:V.78, J:L.101 Hydrogen bonds: J:L.30, J:L.30, J:L.101, J:D.167, J:D.167

3 x STU: STAUROSPORINE(Non-covalent)

STU.3: 15 residues within 4Å: Chain C: L.30, G.31, L.32, G.33, V.38, A.51, M.98, E.99, C.100, L.101, E.150, N.151, L.153, T.166, D.167 7 PLIP interactions: 7 interactions with chain C Hydrophobic interactions: C:L.30, C:V.38, C:L.153, C:D.167 Hydrogen bonds: C:L.32, C:L.101, C:E.150 STU.6: 15 residues within 4Å: Chain G: L.30, G.31, L.32, G.33, V.38, A.51, M.98, E.99, C.100, L.101, E.150, N.151, L.153, T.166, D.167 7 PLIP interactions: 7 interactions with chain G Hydrophobic interactions: G:L.30, G:V.38, G:L.153, G:D.167 Hydrogen bonds: G:L.32, G:L.101, G:E.150 STU.9: 15 residues within 4Å: Chain K: L.30, G.31, L.32, G.33, V.38, A.51, M.98, E.99, C.100, L.101, E.150, N.151, L.153, T.166, D.167 7 PLIP interactions: 7 interactions with chain K Hydrophobic interactions: K:L.30, K:V.38, K:L.153, K:D.167 Hydrogen bonds: K:L.32, K:L.101, K:E.150

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wu, J.-P. et al., The discovery of carboline analogs as potent MAPKAP-K2 inhibitors. Bioorg.Med.Chem.Lett. (2007)

Release Date

2007-07-31

Peptides

MAP kinase-activated protein kinase 2: ABCDEFGHIJKL

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

E
A

F
B

G
C

H
D

I
A

J
B

K
C

L
D

MAP kinase-activated protein kinase 2

Related Entries With Identical Sequence